Metraipolis › archive › dc_455fb427d73d

Targeting metabotropic glutamate receptors for symptomatic and disease-modifying treatment in Parkinson's disease — Europe PMC PMID:41073451

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41073451
DOI
10.1038/s41531-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-09T10:01:39.294Z
SHA-256 of the archived text
504fffb11d9514babb94b804827f4b04a379be1f32bfbd018c8bf4ee87ea8d50
Stable URL of this page
https://metraipolis.com/documento/dc_455fb427d73d

How to cite

Targeting metabotropic glutamate receptors for symptomatic and disease-modifying treatment in Parkinson's disease — Europe PMC PMID:41073451 — Europe PMC (en), https://europepmc.org/article/MED/41073451 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_455fb427d73d (Metraipolis archive dc_455fb427d73d, sha256 504fffb11d9514babb94b804827f4b04a379be1f32bfbd018c8bf4ee87ea8d50)
BibTeX
@misc{dc455fb427d73d,
  title = {Targeting metabotropic glutamate receptors for symptomatic and disease-modifying treatment in Parkinson's disease — Europe PMC PMID:41073451},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41073451},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_455fb427d73d; sha256 504fffb11d9514babb94b804827f4b04a379be1f32bfbd018c8bf4ee87ea8d50},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41073451. Agents can read the archived copy with the MCP tool read_document.